Citius Pharmaceuticals (CTXR) Earnings Date & Reports

Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

CTXR is expected to report earnings to fall 26.47% to -25 cents per share on December 17

Citius Pharmaceuticals CTXR Stock Earnings Reports

Q3'26

Est.

$-0.25

Q2'26

Missed

by $0.37

Q1'26

Missed

by $0.75

Q3'25

Missed

by $0.51

Q2'25

Missed

by $0.85

The last earnings report on August 17 showed earnings per share of -34 cents, missing the estimate of 2 cents. With 97.59K shares outstanding, the current market capitalization sits at 16.48M.

View a ticker or compare two or three

CTXR

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days